UK consumers reduced their purchases of food and alcohol during the recent festive season, a trend attributed by industry experts to the increasing use of weight loss injections. Grocery sales reached £19.6 billion in the four weeks leading up to December 27, marking a 2.5% increase from the previous year, as reported by market research firm NielsenIQ. However, sales volume saw a slight decline of 0.2%.
Retail analysts suggest that this decline in sales volume can be linked to the growing popularity of GLP-1 injections, which emulate a hormone that triggers a quicker feeling of fullness in the body. The National Health Service (NHS) prescribes weight loss injections like Mounjaro and Wegovy, and Ozempic for diabetes, with recent research from University College London estimating that around 1.6 million UK adults have used these injections in the past year.
Experts in the retail sector, such as Jonathan De Mello from JDM Retail, observe a tangible impact of these weight loss injections on consumer behavior, particularly in the grocery sector. De Mello notes a noticeable shift towards reduced consumption among users of GLP-1 injections, affecting high-calorie categories like snacks and alcohol. As this trend gains momentum, retailers are expected to adjust their product offerings to cater to this shift towards “less but better” consumption habits.
Consumer analyst Clive Black from Shore Capital highlights the impact of glucagon-peptide (GLP) drugs on the nation’s eating habits, as evidenced by the decrease in grocery sales volume during the Christmas period. Major retailers are responding to this trend by introducing smaller meal options. For instance, Co-op has rolled out new “mini meals” tailored for individuals with smaller appetites, while Marks & Spencer launched a “nutrient dense” range and Iceland expanded its frozen meal selection with 38 new products.
The influence of weight loss injections on consumer behavior is also acknowledged by industry leaders. Greggs’ CEO recognized the impact of these medications on its business performance, emphasizing the demand for smaller portions and healthier food choices among customers. Tesco’s CEO and Sainsbury’s CEO are closely monitoring consumer trends, especially in light of the rising usage of weight loss medication.
In response to changing consumer preferences and health concerns, retailers are adapting their offerings to align with the evolving demands for healthier and portion-conscious food choices.